However, the number of CD8+ T cells infiltrating the tumor was significantly higher in patients with early-stage colorectal cancer (Stage I–II) than in those with late-stage cancer (Stage III–IV) (p < 0.0001). This evidence concerns the gene CD8A and cancer.